AGL Stock Recent News

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2025 after the market closes on Tuesday, May 6, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international pa.

Here is how Agilon Health (AGL) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.

J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc. AGL following fourth-quarter results posted last month.

Here is how Agilon Health (AGL) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.

agilon health, inc. (NYSE:AGL ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Jack Slevin - Jefferies Ryan Langston - TD Cowen Amir Farahani - Bernstein Jailendra Singh - Truist Securities Michael Ha - Baird Elizabeth Anderson - Evercore Adam Ron - Bank of America Ryan Daniels - William Blair Whit Mayo - Leerink Partners Daniel Grosslight - Citi David Larsen - BTIG George Hill - Deutsche Bank Matt Shea - Needham Operator Hello and welcome to the agilon health Fourth Quarter 2024 Earnings Conference.

While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Agilon Health (AGL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.41 per share a year ago.

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the fourth quarter and fiscal year ended December 31, 2024. “While the underlying strength of our model continues to deliver significant value to patients, payors, and our PCP partners, we are still managing through a challenging Medicare Advantage environment.” said Steve Sell, CEO. “As a result of the strategic.

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 45th Annual TD Cowen Healthcare Conference including a fireside chat presentation on Wednesday, March 5 at 9:50 AM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the “Events & Presentations” section of agilon health's investor.

PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating agilon health, inc. (NYSE: AGL) on behalf of the company's long-term shareholders.